Navigation Links
The AACR commends Senators Kennedy and Hutchison on the 21st Century Cancer ALERT Act
Date:3/26/2009

PHILADELPHIA ― On Thursday, Senators Edward M. Kennedy and Kay Bailey Hutchison introduced legislation that will renew the war on cancer by modernizing and advancing the national cancer program of the United States.

The 21st Century Cancer ALERT (Access to Life-saving Early detection, Research and Treatment) Act represents an important effort to re-assess the national cancer program and improve cancer research, prevention, detection, control and treatment in the United States. The legislation aims to expand and accelerate the search for cures, more effective treatments and better preventive measures while addressing the ongoing needs of the nearly 12 million Americans struggling with cancer today.

"It is imperative that we move with greater speed to strengthen and expand our nation's efforts to prevent, treat and cure cancer," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the American Association for Cancer Research. "The leadership that Senators Kennedy and Hutchison are providing comes at a pivotal moment, when decades of scientific effort are converging to produce a revolution in cancer research and care. The 21st Century Cancer ALERT Act represents a critical step in modernizing the national cancer program and in improving our ability to make headway in the war on cancer."

Since the United States declared war on cancer over four decades ago with the signing of National Cancer Act of 1971, tremendous strides have been made in the understanding of the disease and in the development of therapies that have increased survival and improved the lives of millions. Despite these accomplishments, cancer still kills more than 560,000 Americans each year. Without a greater commitment to cancer research, this number will increase as the baby boom generation grows older. In fact, by 2010, cancer will be the world's number one killer, according to the World Health Organization.

In their endeavor to address the complexities and obstacles confronting the national cancer program, Senators Kennedy and Hutchison have sought input from stakeholders representing every aspect of cancer research and care from the bench to bedside. The AACR applauds their leadership in engaging a wide range of experts to identify key challenges and craft legislation that presents solutions that will foster a new age of discovery and patient care.

"The AACR has been grateful for the opportunity to contribute its expertise in cancer research to this undertaking," said Ray DuBois, M.D., Ph.D., president of the American Association for Cancer Research and provost and executive vice president of The University of Texas M. D. Anderson Cancer Center. "We look forward to working closely with Senators Kennedy and Hutchison to refine this legislation and advance it quickly through Congress for the benefit of cancer patients and their families."


'/>"/>

Contact: Jeremy Moore
Jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Frost & Sullivan Commends Nycomed for Excellence in Product Differentiation Innovation
2. Illinois Hospital Association Commends Governor for Protecting Health Care in State Budget Proposal
3. The National Kidney Foundation of Florida Commends Senator Thad Altman, Representative Ritch Workman for Co-Sponsoring Common Sense Legislation Widely Hailed as Good for Patients, Good for Taxpayers, Good for Florida
4. Virtua Commends Gov. Corzines Charity Care Funding Plan
5. National Multiple Sclerosis Society Commends President Obamas Initial Steps in Removing the Bans on Embryonic Stem Cell Research
6. Christopher & Dana Reeve Foundation Commends President Obamas Decision to Lift Federal Restrictions on Stem Cell Research
7. Save Abandoned Babies Foundation Commends Illinois Hospitals for Being 100% in Compliance in Displaying Safe Haven Signs
8. Leading Proxy Advisory Firm RiskMetrics Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group
9. NACDS Commends Obama's Shared Commitment on Accessible, Quality and Affordable Healthcare
10. Himfr.com Recommends Five Foods for Spring
11. Glass Lewis Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Three Proposals by Dissident Joffe Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... Erlanger Agency has announced a new ... area. The latest campaign focuses on the fight against breast cancer, fundraising for a ... accepted here . , Carmen is a loving single mother of two boys ...
(Date:2/12/2016)... San Ramon, CA (PRWEB) , ... February 12, 2016 , ... ... tissue donation in northern California and Nevada, announced a partnership with San Ramon Regional ... be transferred to the hospital’s facilities as a way to accommodate a more certain ...
(Date:2/12/2016)... FL (PRWEB) , ... February 12, 2016 , ... For ... Dental hygienist Suzan Sweeney, RDH, and dental assistant Terrell Moore shortly before 7 a.m. ... joined dozens of dental professionals, donating their time and skills to help hundreds of ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... “Revolutionizing Cancer Care.” , The print component of “Revolutionizing Cancer Care” ... Pittsburgh/Cleveland, New York, Washington DC/Baltimore, and Seattle, with a circulation of approximately 250,000 ...
(Date:2/12/2016)... ... 12, 2016 , ... Atlantic Information Services, Inc. (AIS) is ... an upcoming Feb. 24 webinar that will discuss ways health plans and PBMs ... as the $1,000-per-pill hepatitis C treatment Sovaldi and high-cost PCSK9 inhibitors to treat ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Ky. , Feb. 12, 2016 /PRNewswire/ ... has completed a $47.1 million Series D ... Cormorant Asset Management, Hillhouse Capital Group and ... Morningside Venture Investments, AJU IB Investment, and ... be used to further advance clinical trials ...
(Date:2/11/2016)... The primary goal of this research is ... the usage of liquid biopsy. Key information the survey ... Timeframe of liquid biopsy adoption amidst future users - ... type - Sample inflow to conduct liquid biopsy tests ... and so on. - Correlation analysis of sample type ...
(Date:2/11/2016)... Feb. 11, 2016  Kindred Biosciences, Inc. (NASDAQ: ... improving the lives of pets, today announced the submission ... New Animal Drug Application (NADA) for Zimeta™ (dipyrone injection, ... (KB0120) of Zimeta for the control of pyrexia (fever) ... --> --> The Chemistry, ...
Breaking Medicine Technology: